| Deborah Flath Anderson, | |
|
1035 Proprietors Rd, Worthington, OH 43085-3230 | |
| (614) 785-1115 | |
| (614) 785-0095 |
| Full Name | Deborah Flath Anderson |
|---|---|
| Gender | Female |
| Speciality | Psychologist - School |
| Location | 1035 Proprietors Rd, Worthington, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407047764 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | SP356 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Flath Anderson, 1035 Proprietors Rd, Worthington, OH 43085-3230 Ph: (614) 785-1115 | Deborah Flath Anderson, 1035 Proprietors Rd, Worthington, OH 43085-3230 Ph: (614) 785-1115 |
News Archive
Controlled release pills and capsules that show a tendency in the standard laboratory test toward "dose dumping" - releasing their medicine in a faster and potentially unsafe manner in patients who have consumed alcohol - should be withheld from the market until proven safe with testing in people. That's the conclusion of a review of existing studies in the September-October issue of ACS' Molecular Pharmaceutics, a bi-monthly journal.
This minimally invasive procedure, pioneering in Spain, has been developed by a team of surgeons at the University Hospital of Navarra, which brings together the greatest experience worldwide in this technique.
The world's first vaccine for a disease that causes misery for millions in Africa could be tested within five years.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
Duke University and the University of Colorado schools of medicine have received a $10 million grant from the National Institute for Nursing Research (NINR), part of the National Institutes of Health, to continue the development of the Palliative Care Research Cooperative Group (PCRC) over the next five years.
› Verified 8 days ago
Dr. Matthew Free, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6797 N High St Ste 214, Worthington, OH 43085 Phone: 614-638-8119 | |
Christina Clark, Psychologist Medicare: Medicare Enrolled Practice Location: 666 High St, Suite 200-d, Worthington, OH 43085 Phone: 614-430-8920 Fax: 614-430-8920 | |
Dr. Catherine M Malkin, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7100 N High St, Suite 205, Worthington, OH 43085 Phone: 614-505-6949 Fax: 614-505-6558 | |
Dr. Sandra L. Shullman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 W Wilson Bridge Rd, Suite 30, Worthington, OH 43085 Phone: 641-573-3200 | |
Dr. Lisa K Mccarthy, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7100 North High Street, Suite 205, Worthington, OH 43085 Phone: 614-888-1800 Fax: 614-888-9664 | |
Dr. Pamela Sue Highlen, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 450 W Wilson Bridge Rd, Suite 350, Worthington, OH 43085 Phone: 614-436-6080 | |
Dr. Richard Keith Russell, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 450 W Wilson Bridge Rd, Suite 350, Worthington, OH 43085 Phone: 614-436-6080 |